Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of 15 mg tolvaptan tablets in healthy Thai volunteers
TCTR20200722001Completed
- Sponsor
- Unison Laboratories
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tolvaptan (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax at 72 hours, AUC0-t at 72 hours and 1 more. Started Oct 2020; status: completed.
02
Drugs
tolvaptan
Beyond the preview
Go deeper on TCTR20200722001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200722001.